News

The National Institute for Health and Care Excellence8d

First NICE-curated guideline announced ahead of World Duchenne Awareness Day

In the lead-up to World Duchenne Awareness Day (Sunday, 7 September), we’re pleased to announce the completion of our first assessment of an externally developed clinical guideline – marking a ...
The National Institute for Health and Care Excellence2d

Fertility clinics must end unproven treatments that don't help couples have babies

Fertility clinics should not offer unproven treatments that don't help people have babies, our independent committee has recommended in draft guidance.
National Institute for Health and Care Excellence17y

Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease

Guidance Standards and indicators Clinical Knowledge Summaries (CKS) British National Formulary (BNF) British National Formulary for Children (BNFC) Life sciences Library and knowledge services What ...
National Institute for Health and Care Excellence7d

Published guidance, NICE advice and quality standards

Pneumonia: diagnosis and management QS110 19 January 2016 2 September 2025 Pneumonia: diagnosis and management NG250 2 September 2025 2 September 2025 Suspected acute respiratory infection in over 16s ...
National Institute for Health and Care Excellence18y

MI – secondary prevention: Secondary prevention in primary and secondary care for patients following a myocardial infarction

This guidance has been updated and replaced by NICE guideline CG172 ...
National Institute for Health and Care Excellence4y

COVID-19 rapid guideline: reducing the risk of venous thromboembolism in over 16s with COVID-19

This guideline has been updated and replaced by NICE rapid guideline on managing COVID-19 (NG191) ...
National Institute for Health and Care Excellence1y

Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes

Access to hybrid closed loop systems will be through a 5‑year phased roll out in line with NHS England's implementation plan. For enquiries about cost-effective pricing, contact Leigh.Carr@supplychain ...
National Institute for Health and Care Excellence4y

Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy

Evidence-based recommendations on niraparib (Zejula) for maintenance treatment of advanced (FIGO stages 3 and 4) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer after ...
National Institute for Health and Care Excellence6y

Intrapartum care for women with existing medical conditions or obstetric complications and their babies

This guideline covers care during labour and birth for women who need extra support because they have a medical condition or complications in their current or previous pregnancy. The guideline also ...
National Institute for Health and Care Excellence9mon

Elranatamab for treating relapsed and refractory multiple myeloma after 3 or more treatments

Evidence-based recommendations on elranatamab (Elrexfio) for treating relapsed and refractory multiple myeloma after 3 or more treatments in adults. Next review: More evidence on elranatamab is being ...
National Institute for Health and Care Excellence1y

Artificial intelligence-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessment

Early value assessment (EVA) guidance on artificial intelligence (AI)-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals. February 2025: The technology Red ...
National Institute for Health and Care Excellence4y

Brigatinib for ALK-positive advanced non-small-cell lung cancer that has not been previously treated with an ALK inhibitor

Evidence-based recommendations on brigatinib (Alunbrig) for anaplastic lymphoma kinase (ALK)-positive advanced non-small-cell lung cancer that has not been previously treated with an ALK inhibitor.